baber/WOPTO huggingface dataset:
Patent EP-0620625-A1 (EP)
Title: Draw-out framework for a circuit breaker
Inventor: BUR MARC
IPC: H02B11/127
Filed: 1994-04-06
Abstract: The present invention relates to a draw-out framework for electrical apparatus, especially for a circuit breaker. This draw-out framework (10) is associated with a connecting baseplate (14) and includes two fixed flanges (12, 13) fixed to this baseplate and two movable flanges (17, 18) attached to two opposite side walls of the circuit breaker (11). The movable flanges each bear two driveshafts (20, 21) respectively engaged in two guide grooves (19) of the fixed flanges. These driveshafts can slide in the guide grooves under the action of ramps formed in operating levers (30) provided with an operating handle (32). The circuit breaker (11) can take up a first plug-in position on the connecting baseplate or a second unplugged position. The shafts (20, 21) each carry a free wheel bearing ring (20a, 21a) and two fixed pins (20b, 20c; 21b, 21c) arranged on either side of the bearing ring. The framework can be adapted to various types of electrical apparatus, especially to three-pole or four-pole circuit breakers. <IMAGE>
Patent EP-0690596-A1 (EP)
Inventor: REGACHE PASCAL
IPC: H04Q3/00
Filed: 1994-06-28
Abstract: In order to schedule the transmission of cells of guaranteed-bandwidth virtual channels, a circular list (27) is provided having a predetermined number of entry slots and each channel with cells to send has a corresponding identifier VCN placed in a respective slot in the list, only one VCN being allowed per slot. The list (27) is advanced through slot by slot and each VCN encountered is processed to cause the transmission of a cell for the corresponding virtual channel. The list (27) is also updated for each slot advanced past by freeing that slot and inserting back into the list any VCN that occupied the slot if that VCN relates to a virtual channel with another cell to transmit. This insertion is effected at an offset from the slot previously occupied by the VCN, dependent on a transmission rate indicator (SRP, PRP) of the virtual channel concerned (45, 46). In the event of the target slot being occupied a conflict resolution procedure (47) is effected based on the relative priority of the channel involved, the unsuccesful channel being displaced to the following slot, subject to availability.
Patent EP-0641787-A1 (EP)
Inventor: NOZULAK JOACHIM
IPC: A61P43/00
Filed: 1994-08-30
Abstract: Compounds of formula I
       
 wherein 

     R₁   is (C 1-4 )alkyl, (C 3-6 )alkenyl, whereby the double bond is not in α-position to the nitrogen atom, or (C 3-7 )cycloalkyl(C 1-2 )alkyl,   R₂   is (C 1-4 )alkoxy, (C 2-6 )alkenyloxy or (C 3-7 )cycloalkyl(C 1-2 )alkoxy, and   R₃   is (C 1-4 )alkylcarbonyl, (C 1-4 )alkyl, α-hydroxy(C 1-4 )alkyl, (C 2-5 )alkenyl, (C 1-4 )alkoxy(C 1-4 )alkyl or (C 3-7 )cycloalkyl,     
 in free base or acid addition salt form, exhibit serotonin 1D (5-HT₁ D )-receptor agonistic activity and are thus useful interalia in the treatment of migraine, depression, anxiety and pain.
Patent EP-0650690-A1 (EP)
Inventor: MOREN LARS GUNNAR
IPC: F04D25/08
Filed: 1994-10-26
Abstract: This invention relates to a device for a vacuum cleaner having a suction nozzle and a dust bag (12) which is connected to the nozzle for instance by means of a tube connection, a turbo fan unit (27) driven by an electric motor and placed after the dust bag seen in the flow direction. The impeller (29) of the turbo fan unit is driven at a speed which is above 50.000 rpm the primary air flow created by the turbo fan unit (27) being arranged to directly or indirectly leave the unit via an outlet (30) to atmosphere. The vacuum cleaner is provided with means (45) by means of which a secondary air flow is created which at least partly cools the electric motor (32) and which flows into the electric motor via one or several inlets (44) for cooling air which are separated from the primary air flow.
Patent EP-0664871-A1 (EP)
Title: STAGED AIR, RECIRCULATING FLUE GAS LOW NO x? BURNER.
Inventor: SYSKA ANDREW J
IPC: F23C6/04
Filed: 1993-10-15
Abstract: A gas-fired burner incorporating an air driven jet pump for mixing air, fuel, and recirculated flue gas is disclosed. The burner is configured for the staged introduction of combustion air to provide a fuel-rich combustion zone and a fuel-lean combustion zone. The burner achieves reduced NOx emission levels in high temperature applications which use preheated combustion air.
Patent EP-0729386-A1 (EP)
Title: Fluid bed for producing and/or processing a particulate material
Inventor: LARSEN TAGE MOLLER
IPC: B01J8/44
Filed: 1993-11-15
Abstract: PCT No. PCT/DK93/00372 Sec. 371 Date Apr. 29, 1996 Sec. 102(e) Date Apr. 29, 1996 PCT Filed Nov. 15, 1993 PCT Pub. No. WO95/13867 PCT Pub. Date May 26, 1995A fluid bed for producing and/or processing a particulate material, said bed comprising a container constituted by two convex parts, through which a perforated plate for supporting a fluidized particle layer is fixed. Nozzles for injection of a treatment liquid are provided in the perforated plate and above the plate filtering means are provided for removal of particles entrained by the fluidizing gas.
Patent EP-0677015-A1 (EP)
Inventor: LIFSHEY ARTHUR
IPC: B65D77/04
Filed: 1994-01-05
Abstract: PCT No. PCT/EP94/00020 Sec. 371 Date Jun. 21, 1995 Sec. 102(e) Date Jun. 21, 1995 PCT Filed Jan. 5, 1994 PCT Pub. No. WO94/15855 PCT Pub. Date Jul. 21, 1994The present invention provides a device for the dropwise delivery of a fluid (6) contained in a flexible vial (4; 4'), the device comprising a tubular case (1) capable of surrounding the vial (4; 4'), which casing is provided with a bottom portion (2; 7) whose inner surface lies opposite the outer surface of the bottom wall (42; 42') of the vial (4; 4'), the bottom portion (2; 7) of the casing (1) being equipped with a resiliently displaceable tab (3; 8) which can be moved so as to press against the bottom wall (42; 42') of the vial (4; 4') in order to squeeze the vial (4; 4') and drive out a drop (60) of fluid.
Patent EP-0636178-A1 (EP)
Inventor: SUZUKI SHINTARO
IPC: A61K38/00
Filed: 1993-12-23
Abstract: Cette invention concerne des séquences de polynucléotides qui codent de nouveaux polypeptides du type cadhérine appelés protocadhérines, et des variantes de ces dernières, ainsi que des procédés et des matériaux utiles pour les produire par recombinaison. Des substances d'anticorps spécifiques aux protocadhérines sont également décrites, lesquelles sont utiles pour moduler la liaison naturelle et/ou les activités de régulation des protocadhérines.
Patent EP-0686113-A1 (EP)
Title: Epicyclic change speed gear hubs
Inventor: RICKELS STEPHEN TERENCE
IPC: B62M11/16
Filed: 1994-02-28
Abstract: An epicyclic bicycle change speed gear hub comprises primary and secondary sun pinions (12) and (13) disposed side-by-side on the spindle (14) of the hub. A split selector key (11) comprising first and second parts (15 and 16) is mounted on a support rod (17) for relative movement axially of the hub. Dogs (19 and 21) on respective parts (15 and 16) can be brought into selective cooperative engagement with splines (31 and 32) inwardly of the sun pinions (12 and 13) to lock the selected pinion to the spindle (14) in drive transmission mode. The selector key (11) is movable axially into abutment with a selector sleeve to effect axial adjustment thereof against the restraint of a return spring to provide for change between high and low gears thus providing a compact arrangement.
Patent EP-0688407-A1 (EP)
Title: Mechanical gearing
Inventor: HOOGENBERG HEERKE
IPC: F16H15/54
Filed: 1994-03-17
Abstract: The invention relates to a mechanical gearing (1). This comprises a frame, a first shaft (2) mounted rotatably on the frame and carrying a pair of friction wheels (3, 4) which are disposed at a distance from each other and which have mutually facing friction surfaces (5, 6) together converging outward, a second shaft (7) which is mounted on the frame parallel to but eccentrically relative to the first shaft (2) and which carries a friction wheel (8) which has an internal annular friction surface (9) situated axially between the friction wheels (3, 4) of the first shaft (2), and a closed belt (10) of mutually abutting push links. The belt (10) forms on mutually opposite sides (11) surfaces co-acting with the pair of friction wheels (3, 4) and on a radially outermost surface forms a surface (12) co-acting with the single belt engaging wheel (8).
Patent EP-0690854-A1 (EP)
Inventor: REITZ DAVID B
IPC: C07D403/10
Filed: 1994-03-08
Abstract: A class of 1-phenyl imidazol-2-one biphenylmethyl compounds is described for use in treatment of circulatory disorders. Compounds of particular interest are angiotensin II antagonists of the formula <CHEM> wherein each of R<1>, R<2> and R<3> is independently selected from hydrogen, alkyl, alkoxy, cyano, halo, hydroxy, nitro, amino, alkylamino,carboxyl, alkoxycarbonyl, formyl, alkylcarbonyl and haloalkylcarbonyl; with the proviso that at least one of R<1>, R<2> and R<3> must be a substituent other than hydrogen, and with the further proviso that when each of R<1> and R<3> is hydrogen, then R<2> cannot be chloro; wherein R<4> is selected from hydrogen, alkyl, halo, haloalkyl, formyl, carboxyl and alkoxyalkyl; wherein R<5> is selected from alkyl, phenyl, phenylalkyl, cycloalkyl and cycloalkylalkyl; and wherein R<6> is an acidic group selected from COOH and <CHEM> or a stereoisomer or a tautomer thereof or a pharmaceutically-acceptable salt thereof. These compounds are particularly useful in treatment or control of hypertension and congestive heart failure.
Patent EP-0693010-A1 (EP)
Title: A method of controlling the closing of a can or container, as well as a closing machine for carrying out the method
Inventor: PEDERSEN TORBEN HOLM
IPC: G01M3/24
Filed: 1994-03-30
Abstract: A method of controlling the closing of cans (3) or containers being closed by means of a closing machine (2) comprising some closing rolls or rollers. The control of the closing is performed by means of a sensor head (7) formed by an accelerometer (8). This is arranged on or adjacent the rolls or rollers closing the cans (3) or the containers. A signal (9) emitted by the accelerometer (8) is compared with known references so as to indicate possible closing errors. In this manner the closing rolls or rollers not only serve to perform the closing, but also serve to indicate possible, atypical vibrations during the closing procedure. These vibrations are analyzed so as to indicate possible closing errors. A machine (2) for closing cans comprises closing rolls or rollers, the control being performed by means of a sensor head (7) in form of an accelerometer arranged adjacent the closing rolls and collecting information. As a result, a signal (9) in form of vibrations can be detected during the actual closing procedure of each can (3) or container, said vibrations optionally being caused by the co-operation of the closing-rolls with the can (3) or the container during the closing procedure. Then the detected signals (9) can be compared with known signals, where the comparison can result in revealing differences related to a malfunctioning during the closing of the can (3) or the container. When the sensor head (7) is arranged adjacent the closing rolls or rollers, the information can be collected at the malfunctioning spot and accordingly where the errors occur.
Patent EP-0697908-A1 (EP)
Title: Apparatus for cleaning endless filtering bands
Inventor: FOSSENG AUDUN
IPC: B01D33/04
Filed: 1994-05-13
Abstract: Cleaning device for endless filtering belts (11) being located within a container (13) of contaminated water for filtering said contaminated water. The filtering belt is journalled over a series of rollers (12, 14, 16, 17) to have a section (20) running generally horizontally with the filter residues facing downward, said section being provided with means (23) for blasting of a cleaning fluid against the filtering belt. Under the means for blasting cleaning fluid there is arranged a collecting gutter (21) with a transport equipment (22) at the bottom for disposal of residues. The cleaning fluid is air blasted with a pressure to give the air a temperature increase.
Patent EP-0706675-A1 (EP)
Inventor: BARNETT GAVIN
IPC: G03B17/53
Filed: 1994-06-27
Abstract: L'invention concerne une cabine de photographie constituée d'un logement droit (2) servant à un matériel photographique, ce logement jouxtant un habitacle circulaire (4). L'habitacle (4) est doté d'une ouverture située sur la partie opposée à l'endroit où le logement (2) jouxte ledit habitacle. Une rampe d'accès en déclivité adjacente à l'ouverture conduit au plancher de l'habitacle (4). Un siège à abattant permet à un utilisateur non handicapé de s'asseoir en abaissant l'abattant; cet abattant est laissé contre la paroi de l'habitacle pour offrir l'espace nécessaire à un utilisateur assis sur un fauteuil roulant. Une porte cintrée (6) sert à ouvrir ou fermer l'entrée de l'habitacle.
Patent EP-0702882-A1 (EP)
Inventor: PARK MICHAEL C
IPC: H04W88/18
Filed: 1994-06-08
Abstract: L'invention concerne un système téléavertisseur (10) assurant un traitement de messages et une commande d'alarme améliorés, dans lequel l'acceptation des messages et la commande d'alarme s'effectuent conditionnellement en fonction de l'heure du jour et du jour de la semaine. Le traitement de messages conditionnels peut comporter l'acceptation ou le rejet de la présentation d'un message en fonction d'une référence temporelle. Une commande d'alarme peut être prévue en fonction de la définition de l'alarme par l'utilisateur de manière à personnaliser la présentation d'alarme de sorte qu'elle soit propre à l'utilisateur. Ainsi, l'utilisateur peut commander de manière mieux appropriée le traitement de messages et la présentation d'alarme selon ses critères personnels.
Patent EP-0708829-A1 (EP)
Inventor: SCHLINGENSIEPEN GEORG-F
IPC: A61K31/7088
Filed: 1994-07-06
Abstract: A pharmaceutical composition comprising an effective amount of a compound which is capable of preventing and treating neuronal injury, degeneration, cell death and/or neoplasms in which expression of c-jun, c-fos or jun-B plays a causal role which compound being an antisense nucleic acid or effective derivative thereof, said antisense nucleic acid hybridizing with an area of the messenger RNA (mRNA) and/or DNA encoding c-jun, c-fos or jun-B.
Patent EP-0724566-A1 (EP)
Inventor: REITZ DAVID B
IPC: A61K31/36
Filed: 1994-07-21
Abstract: A class of 1,2-diarylcyclopentenyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I:    <IMAGE>  I  wherein A is selected from   <IMAGE>    <IMAGE>   each of R1 and R2 is independently selected from hydrido, methyl, ethyl, fluoro, hydroxymethyl, carbomethoxy, trifluoromethyl, carboxyl and fluoromethyl; wherein each of R3, R4, R6 through R9, R11 and R12 is independently selected from hydrido, methyl, fluoro and chloro; and wherein each of R5 and R10 is independently selected from hydrido, fluoro, chloro, bromo, iodo, methyl, ethyl, methoxy, methylthio, cyano, trifluoromethyl, hydroxymethyl, methoxymethyl, methylsulfonyl and sulfamyl; provided that when A is   <IMAGE>   R5 cannot be hydrido when R10 is selected from hydrido, cyano, halo, methyl, trifluoromethyl and methoxy; further provided that R10 cannot be hydrido when R5 is selected from cyano, halo, methyl, trifluoromethyl and methoxy; and further provided that R5 and R10 are not both methoxy; or a pharmaceutically suitable salt thereof.
Patent EP-0714391-A1 (EP)
Inventor: BERRYMAN KENT ALAN
IPC: C07D407/06
Filed: 1994-08-09
Abstract: L'invention concerne des composés de la formule (I), ou leur forme céto-acide de chaîne ouverte tautomère, ou leur sel pharmacutiquement acceptable, formule dans laquelle: R1 est alkyle substitué ou non substitué, linéaire ou ramifié, ayant de 1 à 12 atomes de carbone, cycloalkyle substitué ou non substitué ayant de 3 à 12 atomes de carbone, phényle substitué ayant de 1 à 5 substituants, naphtyle non substitué ou substitué par 1 à 5 substituants, ou hétéroaryle non substitué ou substitué par 1 à 5 substituants; R2 est alkyle substitué ou non substitué, linéaire ou ramifié, ayant de 1 à 12 atomes de carbone, cycloalkyle substitué ou non substitué ayant de 3 à 12 atomes de carbone, aryle non substitué ou substitué par 1 à 5 substituants, hétéroaryle non substitué ou substitué par 1 à 3 substituants; R3 est alkyle substitué ou non substitué, linéaire ou ramifié, de 1 à 12 atomes de carbone, cycloalkyle substitué ou non substitué de 3 à 12 atomes de carbone, aryle non substitué ou substitué par 1 à 5 substituants, hétéroaryle non substitué ou substitué par 1 à 3 substituants; R4 est hydrogène, hydroxy, halogène, SR5, OR5 où R5 est alkyle ou alkyle substitué ayant de 1 à 7 atomes de carbone, NR6R7 où R6 et R7 sont chacun indépendamment hydrogène, alkyle, alkyle substitué, phényle substitué ou non substitué, et (CH2)nOR5 où n est un nombre entier compris entre 1 et 3; X est oxygène, S ou NR8 où R8 est hydrogène, alkyle ou alkyle substitué, à condition que, lorsque R1 est phényle monosubstitué et que le substituant est p-méthoxy, R3 n'est pas phényle non substitué, phényle monosubstitué, ou mésityle; à condition également que, lorsque R2 est alkyle substitué, le substituant n'est pas oxygène en position α de la chaîne furanone et à la condition supplémentaire que R1 et R3 ne sont pas tous les deux alkyle ou alkyle substitué dans la même molécule. L'invention concerne l'utilisation de ces composés comme antagonistes non peptidiques de l'endothéline I, de même que leurs procédés de préparation et leurs compositions pharmaceutiques, lesquelles sont utiles dans le traitement des taux élevés d'endothéline, de l'insuffisance rénale aiguë et chronique, de l'hypertension, de l'infarctus du myocarde, de l'ischémie myocardique, de l'angiospasme cérébral, de l'ischémie cérébrale, de l'infarctus cérébral, de la cirrhose, du choc septique, de l'insuffisance cardiaque, du choc endotoxique, de l'hémorragie sous-arachnoïdienne, des arythmies, de l'asthme, de l'éclampsisme, des troubles athéroscléreux y compris la maladie de Raynaud et la resténose, de l'angine, du cancer, de l'hypertension pulmonaire, de l'ischémie, des lésions de la muqueuse gastrique, du choc hémorragique, de la maladie de l'intestin ischémique, de l'ictus et des diabètes.
Patent EP-0725798-A1 (EP)
Inventor: VINSON GAVIN PAUL
IPC: A61P9/00
Filed: 1994-09-27
Abstract: The present invention relates to a novel hybridoma cell line which secretes monoclonal antibodies capable of binding to the AT1 subtype of the Angiotensin II receptor. It also relates to monoclonal antibodies secreted by the hybridoma, which antibodies may be used in diagnostic test kits as well as having therapeutic applications.
Patent EP-0705217-A1 (EP)
Title: Drive system for a curved escalator
Inventor: BRUNN ERIK
IPC: B66B21/06
Filed: 1994-10-05
Abstract: PCT No. PCT/EP94/03291 Sec. 371 Date Apr. 9, 1996 Sec. 102(e) Date Apr. 9, 1996 PCT Filed Oct. 5, 1994 PCT Pub. No. WO95/10477 PCT Pub. Date Apr. 20, 1995A drive system for a curved escalator which has a frame, a transport section including steps, return tracks and guide tracks, and a drive connected to the transport section. The drive system includes: chain wheels connectable to the drive; and chains engaging the chain wheels hingeable in lateral edge areas of the steps, the chains being disposed parallel to one another, each of the chains comprising interior and exterior brackets. The drive system further includes shaft sections disposed adjacent corresponding ones of the brackets and further being adapted to be disposed at respective edge areas of each step; rollers connected to respective ends of each of the shaft sections, each of the shaft sections projecting through a corresponding one of the rollers and being fixed, at a face end thereof, in a wall area of a corresponding one of the interior brackets which is adapted to face outer frame areas of the frame; and traction rollers placed at a distance from the rollers. Bushings are respectively disposed at both end sections of the brackets. Each of the rollers includes a spherical bearing disposed therein, is seated in one dimension between corresponding ones of the interior brackets which are parallel to one another, is adjacent a corresponding one of the shaft sections, and is further seated in another dimension between corresponding ones of the bushings at both end sections of the brackets.
Patent EP-0722454-A1 (EP)
Inventor: AMATO JOSEPH S
IPC: A61P33/00
Filed: 1994-10-04
Abstract: There is disclosed a novel form of avermectin compounds wherein the avermectin compounds are crystallized as alcohol solvates to greatly enhance stability of the avermectin drug during long-term storage. The avermectin compounds have utility as highly potent antiparasitic, insecticidal, and anthelmintic agents and compositions for that use are also disclosed.
Patent EP-0664428-A1 (EP)
Inventor: LE GAUYER PHILIPPE
IPC: B21D39/04
Filed: 1995-01-18
Abstract: The tube consists of a body (12) of elongated cross-section, with two long faces (18) and two short ones (24). The end (14) is also of elongated cross-section, but with different dimensions, having two long sides (22) and two short ones, and a transitional section (16). The transitional section of the tube has two sloping surfaces (26) which connect the longer faces of the body and end of the tube, and at least one curved face (28) joining their shorter surfaces. The long surfaces of the body and end and the inclined surfaces connecting them are all flat, with the transitional section surfaces set at an angle of 30 degrees to the axis of the tube.
Patent EP-0669333-A1 (EP)
Inventor: ALMANSA CARMEN
IPC: A61K31/435
Filed: 1995-02-24
Abstract: The present invention relates to new imidazopyridine derivatives of formula I
     wherein: one of A, B, C and D is N and the other are CR, wherein each R independently represents hydrogen, C 1-4  alkyl, COOH or halogen; R 1  represents C 1-4  alkyl or C 3 - 7  cycloalkyl; Ar 1  represents phenylene or pyridylene which can be optionally substituted; V represents C 1-4  alkyl, C 3 - 7  cycloalkyl, aryl, aryl-(C 1-4 )alkyl or a 5- or 6-membered aromatic heterocycle; the group X-Y represents C = C or CH-CR 3 ; R 3  represents hydrogen, C 1-4  alkyl or aryl-(C 1-4 )alkyl; Z represents among others -CO 2 R 4 , -tetrazol-5-yl, -CONHS0 2 R 4 , -CONR 4 R 5 , -CH 2 NHSO 2 R 4 ; R 4  and R 5  independently represent hydrogen, C 1-4  alkyl, aryl, aryl-(C 1-4 )alkyl or perfluoro-(C 1-4 )alkyl; W represents hydrogen, cyano, C 1-4  alkyl, C 1-4  haloalkyl, C3-7 cycloalkyl, aryl, aryl-(C 1-4 )alkyl, C 1  - 4  alkylsulfonyl, C 1  - 4  alkylsulfinyl, C 1  - 4  alkylthio, C 1  - 4  alkoxy, C 1 - 4  alkylcarbonyl, halogen, hydroxymethyl or C 1 - 4  alkoxymethyl, or W can have any of the meanings disclosed for Z. These compounds are angiotensin II antagonists.
Patent EP-0680974-A1 (EP)
Title: Novel muramyldipeptide derivatives
Inventor: OKI MASAHARU
IPC: A61K38/14
Filed: 1991-10-28
Abstract: Novel muramyldipeptide derivatives such as [6-0-(2-tetradecylhexadecanoyl)-N-acetylmuramoyl]-L-alanyl-D-glutamide and [6-0-(2-tetradecylhexadecanoyl)-N-acetylmuramoyl]-L-alanyl-N -methyl-D-glutamamide are provided. The muramyldipeptide derivatives are excellent compound as an adjuvant or a constituting component of virosome vaccine.